According to UroGen Pharma's latest financial reports and stock price the company's current Operating Margin is -124.59%. At the end of 2023 the company had an Operating Margin of -101.08%.
Year | Operating Margin | Change |
---|---|---|
2023 | -101.08% | -34.68% |
2022 | -154.75% | -32.03% |
2021 | -227.66% | -78.81% |
2020 | -1,074.15% | -99.82% |
2019 | -608,211.11% | 8789.12% |
2018 | -6,842.20% | 2697.93% |
2017 | -244.55% | -5472.03% |
2016 | 4.55% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.